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Community 
Vaccinators in 
the Workplace
To the Editor: Adult vaccination 
rates are low (1), and workplaces 
are a useful location for increasing 
vaccination (2). In 2008, only 41% 
of US workers 50–64 years of age 
reported vaccination against inﬂ  uenza 
virus (3). Workplace vaccination is 
common and increases with employer 
size (4). Among adults, the workplace 
is the most common site for inﬂ  uenza 
vaccination for persons 18–49 years 
of age and second most common for 
persons 50–64 years (2). Offering 
vaccination in the workplace increases 
vaccination coverage (5).
Consistent with guidelines and 
economic incentives, employers 
have focused workplace vaccination 
on seasonal inﬂ  uenza  (4), but the 
workplace has also been a key site 
for vaccination against inﬂ  uenza  A 
pandemic (H1N1) 2009 and could 
be a site for other adult vaccinations. 
The most recent guidelines from the 
Advisory Committee on Immunization 
Practices recommend annual inﬂ  uenza 
vaccination of all adults (6). In most 
years, the seasonal inﬂ  uenza vaccine 
and predominant circulating viruses are 
well matched, and employers have an 
economic incentive to decrease worker 
absenteeism by increasing inﬂ  uenza 
vaccination (7). The workplace is also 
potentially a site for delivery of herpes 
zoster, pneumococcal, and tetanus-
diphtheria-pertussis vaccines (6).
Our experience with employers 
suggests that most contract with 
external organizations (i.e., community 
vaccinators) to provide workplace 
vaccination, but we found little or no 
information about these organizations 
in the literature. Therefore, we 
interviewed community vaccinators 
about their 2009 experience with 
workplace vaccination against 
seasonal inﬂ  uenza virus and pandemic 
(H1N1) 2009 virus, their business 
practices, barriers encountered, and 
delivery of other adult vaccines.
We selected a diverse study 
population of community vaccinators. 
We combined the 10 US Department 
of Health and Human Services regions 
to create 5 study regions. Beginning 
with a list of vaccinators provided 
by the Centers for Disease Control 
and Prevention (Atlanta, GA, USA) 
and searching with Google for “on-
site vaccinators,” we identiﬁ  ed  17 
national and 28 local vaccinators 
(full list available from the authors). 
We selected at least 1 national and 
1 local vaccinator from each region 
and then purposively sampled 
them to increase geographic and 
organizational diversity. Our sample 
comprised 5 national vaccinators, 
7 local vaccinators serving urban 
and rural workplaces, a mobile-
clinic vaccinator, a visiting nurses 
association, and an occupational 
health specialist.
The qualitative study (8) used 
a structured telephone interview 
with community vaccinators’ lead 
personnel responsible for worker 
vaccination. Our theoretical approach 
was content analysis. After 2 pilot 
interviews, 2 interviewers completed 
10 additional interviews. Because 
the questions in the pilot and ﬁ  nal 
interviews were similar, we analyzed 
both groups together and report here 
on all 12 interviews. We designed 
the interviews to last <20 minutes 
and conducted them during March 
and April 2010. One interviewer 
used Atlas.ti software (Atlas.
ti Software Development, Berlin, 
Germany) to code the interviews, 
with review and concurrence from 
the second interviewer. The Human 
Subjects Division of the University 
of Washington approved this study as 
exempt from review.
Challenges reported for the 2009 
inﬂ  uenza vaccination season included 
the need for workers to receive 2 
vaccines (seasonal and pandemic 
[H1N1] 2009) and a mismatch 
between vaccine demand and supply, 
resulting in delayed or lost business 
(9/12 respondents). Some vaccinators 
found the season more challenging 
than in prior seasons (4/5 national; 2/7 
local), yet most reported having added 
clients (4/5 national; 4/7 local).
Vaccinators’ reported business 
practices include vaccinating at 
sites in addition to workplaces, for 
example, churches and faith-based 
settings (9 vaccinators), schools (9), 
and community centers (8). Most (9) 
reported vaccinating on multiple work 
shifts and at multiple worksites. Ten 
vaccinators also reported they can 
help employers publicize workplace 
vaccination events. Most did not 
report patient-level vaccination 
information to health plans (10 
vaccinators), primary-care providers 
(9), or registries (8). Many directly 
bill Medicare (8) and private insurers 
(7) if asked.
Additional  ﬁ  ndings  related 
to barriers and delivery of other 
vaccines. Commonly reported barriers 
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to increasing workplace vaccination 
rates were worker reluctance (voiced 
as “I’m too busy,” “I don’t need it,” or 
“It gives me the ﬂ  u”) (10 vaccinators); 
worker out-of-pocket costs (9); and 
low worker awareness of workplace 
vaccination events (5). Other vaccines 
offered by these workplace vaccinators 
included the following: tetanus-
diphtheria-pertussis (10 vaccinators), 
pneumococcal (10), hepatitis A and B 
(7), and herpes zoster (4).
This qualitative study, although 
small and not necessarily representative, 
found remarkable consistency across 
community vaccinators. Vaccinators 
were challenged by the pandemic 
(H1N1) 2009 vaccination season, but 
the season also provided new clients. 
Most reported vaccinating at diverse 
sites in addition to workplaces, and 
most already vaccinated against 
diseases other than inﬂ  uenza. 
Vaccinators consistently identiﬁ  ed 
workers’ reluctance and out-of-
pocket costs, and poor publicizing 
of workplace vaccination events as 
remediable barriers to vaccination. 
Tackling of these barriers is supported 
by the literature (9,10) and the Guide 
to Community Preventive Services (5).
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Methicillin-
Resistant 
Staphylococcus 
aureus in Retail 
Meat, Detroit, 
Michigan, USA
To the Editor: Because 
methicillin-resistant  Staphylococcus 
aureus (MRSA) has been identiﬁ  ed 
in retail meat worldwide (1–4), the 
potential exists for its transmission 
to humans. Of the various meat 
products surveyed, pork had the 
highest contamination rate in the 
United States and Canada (1,2), as did 
beef in South Korea (3) and poultry 
in the Netherlands (4). The study in 
South Korea also observed MRSA 
from chicken, which demonstrated 
sequence type (ST) 692 by multilocus 
sequence typing (MLST), a type 
distinct from that isolated in beef and 
pork. Despite sample size variations, 
these studies suggested that MRSA 
contamination in different meat 
categories can vary by location and 
that molecular distinction may exist 
among MRSA isolates in meat of 
different origin.
We collected 289 raw meat 
samples (156 beef, 76 chicken, and 
57 turkey) from 30 grocery stores 
in Detroit, Michigan, USA, during 
August 2009–January 2010. Up to 
3 presumptive S. aureus colonies 
per sample were identiﬁ  ed  by 
coagulase test and species-speciﬁ  c 
PCR (1). Antimicrobial drug MICs 
were determined and interpreted 
according to Clinical and Laboratory 
Standards Institute guidelines (5). S. 
aureus were characterized by pulsed-
ﬁ   eld gel electrophoresis (PFGE), 
mecA identiﬁ  cation,  staphylococcal 
cassette chromosome (SCC) mec 
typing, Panton-Valentine leukocidin 
identiﬁ  cation, agr typing, MLST, and 
spa typing as described (1,6).
Sixty-ﬁ   ve (22.5%) samples 
yielded S. aureus: 32 beef (20.5%), 19 
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